Others titles
- Transparency Reports and Reporting of Physician Ownership or Investment Interests
- Research Payment Data
- Research Payment Analytics
- Covered Recipients Analytics (Physicians, Teaching Hospitals, Non Covered Recipients)
- Manufacturer’s or GPO’s Research Payments Analytics
- Disputed / Undisputed Records Analytics
- Research subjects Analytics (Drugs or Devices)
Keywords
- Open Payments
- Affordable Care Act
- Sunshine Act
- Transparency programs
- Research Payments Detail
CMS Research Payment Details for Covered Recipients 2013
Dataset for reported Research Payments for the 2013 program year. Research payment records provide the total value of a payment or other transfer of value made for research purposes to a particular recipient for a particular date.
This dataset has been refreshed to include the most recent attested-to data for program year 2013.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
Open Payments, which is managed by the Centers for Medicare & Medicaid Services (CMS), is a national disclosure program created by the Affordable Care Act (ACA) that promotes transparency and accountability by helping consumers understand the financial relationships between pharmaceutical and medical device industries and physicians and teaching hospitals. These financial relationships may include consulting fees, research grants, travel reimbursements, and payments made from the industry to medical practitioners.
Each record includes identifying information for the applicable manufacturer or applicable Group Purchasing Organization (GPO) who made the payment, and identifying information for the recipient. Information is also provided for up to five principal investigators associated with the payment.
Each record also lists, if applicable, up to five covered drugs or biologicals, or up to five covered devices or medical supplies, that were part of the research payment or other transfers of value.
Each record now includes a Change Type indicator field. In General Payment, Research Payment, and Ownership/Investment records, the Change Type value indicates if the record is new (NEW), if the record is being published for the first time despite having been submitted during an earlier submission period due to the record not being eligible for publication until the current publication (ADD), if the record has been previously published but modified since its last publication (CHANGED), or if the record is being republished without change in the current publication (UNCHANGED). A record whose only change since the last publication is a change to its dispute status is categorized as a changed record.
About this Dataset
Data Info
Date Created | 2014-06 |
---|---|
Last Modified | 2020-01-03 |
Version | 2020-01-03 |
Update Frequency |
Annual |
Temporal Coverage |
2013-01 to 2013-12 |
Spatial Coverage |
United States |
Source | John Snow Labs; Centers of Medicare and Medicaid Services (CMS); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Open Payments, Affordable Care Act, Sunshine Act, Transparency programs, Research Payments Detail |
Other Titles | Transparency Reports and Reporting of Physician Ownership or Investment Interests, Research Payment Data, Research Payment Analytics, Covered Recipients Analytics (Physicians, Teaching Hospitals, Non Covered Recipients), Manufacturer’s or GPO’s Research Payments Analytics, Disputed / Undisputed Records Analytics, Research subjects Analytics (Drugs or Devices) |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Change_Type | Indicator showing if the payment record is New, Added, Modified, or Unchanged in the current publication compared to the previous publication. | string | required : 1enum : Array ( [0] => NEW [1] => ADD [2] => CHANGED [3] => UNCHANGED ) maxLength : 20 |
Covered_Recipient_Type | Indicator showing if recipient of the payment or other transfer of value is a physician covered recipient, teaching hospital covered recipient, non-covered recipient entity or non-covered recipient individual | string | required : 1maxLength : 50 |
Noncovered_Recipient_Entity_Name | The name of the non-covered recipient entity receiving the payment or other transfer of value | string | maxLength : 50 |
Teaching_Hospital_CCN | A unique identifying number (CMS Certification Number) of the Teaching Hospital receiving the payment or other transfer of value | string | maxLength : 6 |
Teaching_Hospital_ID | System-generated unique identifier of the teaching hospital receiving the payment or other transfer of value | integer | level : Nominal |
Teaching_Hospital_Name | The name of the teaching hospital receiving the payment or other transfer of value – the name displayed is as listed in the CMS teaching hospital list | string | maxLength : 100 |
Physician_Profile_ID | System-generated unique identifier for physician profile receiving the payment or other transfer of value | integer | level : Nominal |
Physician_First_Name | First name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entity | string | maxLength : 20 |
Physician_Middle_Name | Middle name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entity | string | maxLength : 20 |
Physician_Last_Name | Last name of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entity | string | maxLength : 35 |
Physician_Name_Suffix | Name suffix of the physician (covered recipient) receiving the payment or other transfer of value, as reported by the submitting entity | string | maxLength : 5 |
Recipient_Primary_Business_Street_Address_Line1 | The first line of the primary business street address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value | string | maxLength : 55 |
Recipient_Primary_Business_Street_Address_Line2 | The second line of the primary business street address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value | string | maxLength : 55 |
Recipient_City | The primary practice/business address city of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value | string | maxLength : 40 |
Recipient_State | The state or territory abbreviation of the primary business address of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary business address is in the United States | string | maxLength : 2 |
Recipient_Zip_Code | The 9-digit zip code for the primary business location of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Recipient_Country | The primary practice/business address country of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Recipient_Province | The primary practice/business province name of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Recipient_Postal_Code | The international postal code for the primary business location of the physician or teaching hospital or non-covered recipient entity receiving the payment or other transfer of value if the primary business address is outside the United States | string | maxLength : 20 |
Physician_Primary_Type | Primary type name of medicine practiced by the physician (covered recipient) | string | maxLength : 50 |
Physician_Specialty | Physician's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Physician_License_State_Code1 | The state license number of the covered recipient physician, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Physician_License_State_Code2 | The state license number of the covered recipient physician, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Physician_License_State_Code3 | The state license number of the covered recipient physician, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Physician_License_State_Code4 | The state license number of the covered recipient physician, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Physician_License_State_Code5 | The state license number of the covered recipient physician, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_1_Profile_ID | An identifier for principal investigator profile after validation | integer | level : Nominal |
Principal_Investigator_1_First_Name | First name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_1_Middle_Name | Middle name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_1_Last_Name | Last name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 35 |
Principal_Investigator_1_Name_Suffix | Name suffix of the principal investigator associated with the payment or other transfer of value | string | maxLength : 5 |
Principal_Investigator_1_Business_Street_Address_Line1 | The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_1_Business_Street_Address_Line2 | The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_1_City | The primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 40 |
Principal_Investigator_1_State | The primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 2 |
Principal_Investigator_1_Zip_Code | The 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Principal_Investigator_1_Country | The primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Principal_Investigator_1_Province | The primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Principal_Investigator_1_Postal_Code | The international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States | string | maxLength : 20 |
Principal_Investigator_1_Primary_Type | Primary type name of medicine practiced by the principal investigator | string | maxLength : 100 |
Principal_Investigator_1_Specialty | Principal investigator's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Principal_Investigator_1_License_State_Code1 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_1_License_State_Code2 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_1_License_State_Code3 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_1_License_State_Code4 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_1_License_State_Code5 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_2_Profile_ID | An identifier for principal investigator profile after validation | integer | level : Nominal |
Principal_Investigator_2_First_Name | First name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_2_Middle_Name | Middle name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_2_Last_Name | Last name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 35 |
Principal_Investigator_2_Name_Suffix | Name suffix of the principal investigator associated with the payment or other transfer of value | string | maxLength : 5 |
Principal_Investigator_2_Business_Street_Address_Line1 | The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_2_Business_Street_Address_Line2 | The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_2_City | The primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 40 |
Principal_Investigator_2_State | The primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 2 |
Principal_Investigator_2_Zip_Code | The 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Principal_Investigator_2_Country | The primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Principal_Investigator_2_Province | The primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Principal_Investigator_2_Postal_Code | The international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States | string | maxLength : 20 |
Principal_Investigator_2_Primary_Type | Primary type name of medicine practiced by the principal investigator | string | maxLength : 100 |
Principal_Investigator_2_Specialty | Principal investigator's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Principal_Investigator_2_License_State_Code1 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_2_License_State_Code2 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_2_License_State_Code3 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_2_License_State_Code4 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_2_License_State_Code5 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_3_Profile_ID | An identifier for principal investigator profile after validation | integer | level : Nominal |
Principal_Investigator_3_First_Name | First name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_3_Middle_Name | Middle name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_3_Last_Name | Last name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 35 |
Principal_Investigator_3_Name_Suffix | Name suffix of the principal investigator associated with the payment or other transfer of value | string | maxLength : 5 |
Principal_Investigator_3_Business_Street_Address_Line1 | The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_3_Business_Street_Address_Line2 | The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_3_City | The primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 40 |
Principal_Investigator_3_State | The primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 2 |
Principal_Investigator_3_Zip_Code | The 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Principal_Investigator_3_Country | The primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Principal_Investigator_3_Province | The primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Principal_Investigator_3_Postal_Code | The international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States | string | maxLength : 20 |
Principal_Investigator_3_Primary_Type | Primary type name of medicine practiced by the principal investigator | string | maxLength : 100 |
Principal_Investigator_3_Specialty | Principal investigator's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Principal_Investigator_3_License_State_Code1 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_3_License_State_Code2 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_3_License_State_Code3 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_3_License_State_Code4 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_3_License_State_Code5 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_4_Profile_ID | An identifier for principal investigator profile after validation | integer | level : Nominal |
Principal_Investigator_4_First_Name | First name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_4_Middle_Name | Middle name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_4_Last_Name | Last name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 35 |
Principal_Investigator_4_Name_Suffix | Name suffix of the principal investigator associated with the payment or other transfer of value | string | maxLength : 5 |
Principal_Investigator_4_Business_Street_Address_Line1 | The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_4_Business_Street_Address_Line2 | The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_4_City | The primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 40 |
Principal_Investigator_4_State | The primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 2 |
Principal_Investigator_4_Zip_Code | The 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Principal_Investigator_4_Country | The primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Principal_Investigator_4_Province | The primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Principal_Investigator_4_Postal_Code | The international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States | string | maxLength : 20 |
Principal_Investigator_4_Primary_Type | Primary type name of medicine practiced by the principal investigator | string | maxLength : 100 |
Principal_Investigator_4_Specialty | Principal investigator's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Principal_Investigator_4_License_State_Code1 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_4_License_State_Code2 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_4_License_State_Code3 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_4_License_State_Code4 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_4_License_State_Code5 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_5_Profile_ID | An identifier for principal investigator profile after validation | integer | level : Nominal |
Principal_Investigator_5_First_Name | First name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_5_Middle_Name | Middle name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 20 |
Principal_Investigator_5_Last_Name | Last name of the principal investigator associated with the payment or other transfer of value | string | maxLength : 35 |
Principal_Investigator_5_Name_Suffix | Name suffix of the principal investigator associated with the payment or other transfer of value | string | maxLength : 5 |
Principal_Investigator_5_Business_Street_Address_Line1 | The first line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_5_Business_Street_Address_Line2 | The second line of the primary practice/business street address of the principal investigator associated with the payment or other transfer of value | string | maxLength : 55 |
Principal_Investigator_5_City | The primary practice/business city of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 40 |
Principal_Investigator_5_State | The primary practice/business state or territory abbreviation of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 2 |
Principal_Investigator_5_Zip_Code | The 9-digit zip code for the primary business location of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 10 |
Principal_Investigator_5_Country | The primary practice/business address country name of the principal investigator associated with the payment or other transfer of value if the primary practice address is in the United States | string | maxLength : 100 |
Principal_Investigator_5_Province | The primary practice/business province name of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States, and if applicable | string | maxLength : 20 |
Principal_Investigator_5_Postal_Code | The international postal code for the primary practice/business location of the principal investigator associated with the payment or other transfer of value, if the primary practice/business address is outside the United States | string | maxLength : 20 |
Principal_Investigator_5_Primary_Type | Primary type name of medicine practiced by the principal investigator | string | maxLength : 100 |
Principal_Investigator_5_Specialty | Principal investigator's single specialty chosen from the standardized "provider taxonomy" code list | string | maxLength : 300 |
Principal_Investigator_5_License_State_Code1 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_5_License_State_Code2 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_5_License_State_Code3 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_5_License_State_Code4 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Principal_Investigator_5_License_State_Code5 | The state license number of the principal investigator, which is a 2-letter state abbreviation. | string | maxLength : 2 |
Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name | Textual proper name of either the submitting applicable manufacturer or applicable GPO | string | required : 1maxLength : 100 |
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID | System-generated unique identifier of the applicable manufacturer or applicable GPO making the payment or other transfer of value | integer | level : Nominalrequired : 1 |
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name | Textual proper name of the applicable manufacturer or applicable GPO making the payment or other transfer of value | string | required : 1maxLength : 100 |
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State | State name of the submitting applicable manufacturer or applicable GPO | string | maxLength : 2 |
Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country | Country name of the applicable manufacturer or applicable GPO | string | required : 1maxLength : 100 |
Product_Indicator | Indicator allows the applicable manufacturer or applicable GPO to select whether the payment or other transfer of value is associated with | string | required : 1maxLength : 50 |
Name_of_Associated_Covered_Drug_or_Biological1 | The marketed name of the drug or biological associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Drug_or_Biological2 | The marketed name of the drug or biological associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Drug_or_Biological3 | The marketed name of the drug or biological associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Drug_or_Biological4 | The marketed name of the drug or biological associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Drug_or_Biological5 | The marketed name of the drug or biological associated with this payment or other transfer of value | string | maxLength : 100 |
NDC_of_Associated_Covered_Drug_or_Biological1 | The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable) | string | maxLength : 12 |
NDC_of_Associated_Covered_Drug_or_Biological2 | The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable) | string | maxLength : 12 |
NDC_of_Associated_Covered_Drug_or_Biological3 | The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable) | string | maxLength : 12 |
NDC_of_Associated_Covered_Drug_or_Biological4 | The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable) | string | maxLength : 12 |
NDC_of_Associated_Covered_Drug_or_Biological5 | The National Drug Code, if any,of the drug or biological associated with the payment or other transfer of value (if applicable) | string | maxLength : 12 |
Name_of_Associated_Covered_Device_or_Medical_Supply1 | The marketed name of the device or medical supply associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Device_or_Medical_Supply2 | The marketed name of the device or medical supply associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Device_or_Medical_Supply3 | The marketed name of the device or medical supply associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Device_or_Medical_Supply4 | The marketed name of the device or medical supply associated with this payment or other transfer of value | string | maxLength : 100 |
Name_of_Associated_Covered_Device_or_Medical_Supply5 | The marketed name of the device or medical supply associated with this payment or other transfer of value | string | maxLength : 100 |
Total_Amount_of_Payment_USDollars | US dollar amount of payment or other transfer of value to recipient | number | level : Ratiorequired : 1 |
Date_of_Payment | If a singular payment, then this is the actual date the payment was issued; if a series of payments or an aggregated set of payments, this is the date of the first payment to the covered recipient in this program year | date | required : 1 |
Form_of_Payment_or_Transfer_of_Value | The method of payment used to pay the covered recipient or to make the transfer of value | string | required : 1maxLength : 100 |
Expenditure_Category1 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Expenditure_Category2 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Expenditure_Category3 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Expenditure_Category4 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Expenditure_Category5 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Expenditure_Category6 | Contextual category for this research payment or other transfer of value | string | maxLength : 50 |
Is_Preclinical_Research_Indicator | Indicator showing if payment or other transfer of value is related to research, which is pre-clinical | boolean | - |
Is_Delay_in_Publication_Indicator | Indicator showing if an applicable manufacturer or applicable GPO is requesting a delay in publication of a payment or other transfer of value | boolean | - |
Name_of_Study | The textual name of the study for which the covered recipient is receiving this payment or other transfer of value | string | maxLength : 500 |
Is_Dispute_Status_for_Publication | Indicates whether the payment or other transfer of value is disputed by the covered recipient or not | boolean | - |
Record_ID | System-assigned identifier to the general transaction at the time of submission | integer | level : Nominalrequired : 1 |
Program_Year | The year in which the payment occurred | date | required : 1 |
Payment_Publication_Date | The predefined date when the payment or other transfer of value is scheduled to be published | date | required : 1 |
ClinicalTrials_Gov_Identifier | Identifier assigned if research study is registered on clinicaltrials.gov | string | maxLength : 11 |
Research_Information_Link | Optional link to information relevant to the research study for which this payment or other transfer of value is being reported | string | maxLength : 2083 |
Context_of_Research | Textual description of research context or research objectives | string | maxLength : 500 |
Data Preview
Change Type | Covered Recipient Type | Noncovered Recipient Entity Name | Teaching Hospital CCN | Teaching Hospital ID | Teaching Hospital Name | Physician Profile ID | Physician First Name | Physician Middle Name | Physician Last Name | Physician Name Suffix | Recipient Primary Business Street Address Line1 | Recipient Primary Business Street Address Line2 | Recipient City | Recipient State | Recipient Zip Code | Recipient Country | Recipient Province | Recipient Postal Code | Physician Primary Type | Physician Specialty | Physician License State Code1 | Physician License State Code2 | Physician License State Code3 | Physician License State Code4 | Physician License State Code5 | Principal Investigator 1 Profile ID | Principal Investigator 1 First Name | Principal Investigator 1 Middle Name | Principal Investigator 1 Last Name | Principal Investigator 1 Name Suffix | Principal Investigator 1 Business Street Address Line1 | Principal Investigator 1 Business Street Address Line2 | Principal Investigator 1 City | Principal Investigator 1 State | Principal Investigator 1 Zip Code | Principal Investigator 1 Country | Principal Investigator 1 Province | Principal Investigator 1 Postal Code | Principal Investigator 1 Primary Type | Principal Investigator 1 Specialty | Principal Investigator 1 License State Code1 | Principal Investigator 1 License State Code2 | Principal Investigator 1 License State Code3 | Principal Investigator 1 License State Code4 | Principal Investigator 1 License State Code5 | Principal Investigator 2 Profile ID | Principal Investigator 2 First Name | Principal Investigator 2 Middle Name | Principal Investigator 2 Last Name | Principal Investigator 2 Name Suffix | Principal Investigator 2 Business Street Address Line1 | Principal Investigator 2 Business Street Address Line2 | Principal Investigator 2 City | Principal Investigator 2 State | Principal Investigator 2 Zip Code | Principal Investigator 2 Country | Principal Investigator 2 Province | Principal Investigator 2 Postal Code | Principal Investigator 2 Primary Type | Principal Investigator 2 Specialty | Principal Investigator 2 License State Code1 | Principal Investigator 2 License State Code2 | Principal Investigator 2 License State Code3 | Principal Investigator 2 License State Code4 | Principal Investigator 2 License State Code5 | Principal Investigator 3 Profile ID | Principal Investigator 3 First Name | Principal Investigator 3 Middle Name | Principal Investigator 3 Last Name | Principal Investigator 3 Name Suffix | Principal Investigator 3 Business Street Address Line1 | Principal Investigator 3 Business Street Address Line2 | Principal Investigator 3 City | Principal Investigator 3 State | Principal Investigator 3 Zip Code | Principal Investigator 3 Country | Principal Investigator 3 Province | Principal Investigator 3 Postal Code | Principal Investigator 3 Primary Type | Principal Investigator 3 Specialty | Principal Investigator 3 License State Code1 | Principal Investigator 3 License State Code2 | Principal Investigator 3 License State Code3 | Principal Investigator 3 License State Code4 | Principal Investigator 3 License State Code5 | Principal Investigator 4 Profile ID | Principal Investigator 4 First Name | Principal Investigator 4 Middle Name | Principal Investigator 4 Last Name | Principal Investigator 4 Name Suffix | Principal Investigator 4 Business Street Address Line1 | Principal Investigator 4 Business Street Address Line2 | Principal Investigator 4 City | Principal Investigator 4 State | Principal Investigator 4 Zip Code | Principal Investigator 4 Country | Principal Investigator 4 Province | Principal Investigator 4 Postal Code | Principal Investigator 4 Primary Type | Principal Investigator 4 Specialty | Principal Investigator 4 License State Code1 | Principal Investigator 4 License State Code2 | Principal Investigator 4 License State Code3 | Principal Investigator 4 License State Code4 | Principal Investigator 4 License State Code5 | Principal Investigator 5 Profile ID | Principal Investigator 5 First Name | Principal Investigator 5 Middle Name | Principal Investigator 5 Last Name | Principal Investigator 5 Name Suffix | Principal Investigator 5 Business Street Address Line1 | Principal Investigator 5 Business Street Address Line2 | Principal Investigator 5 City | Principal Investigator 5 State | Principal Investigator 5 Zip Code | Principal Investigator 5 Country | Principal Investigator 5 Province | Principal Investigator 5 Postal Code | Principal Investigator 5 Primary Type | Principal Investigator 5 Specialty | Principal Investigator 5 License State Code1 | Principal Investigator 5 License State Code2 | Principal Investigator 5 License State Code3 | Principal Investigator 5 License State Code4 | Principal Investigator 5 License State Code5 | Submitting Applicable Manufacturer or Applicable GPO Name | Applicable Manufacturer or Applicable GPO Making Payment ID | Applicable Manufacturer or Applicable GPO Making Payment Name | Applicable Manufacturer or Applicable GPO Making Payment State | Applicable Manufacturer or Applicable GPO Making Payment Country | Product Indicator | Name of Associated Covered Drug or Biological1 | Name of Associated Covered Drug or Biological2 | Name of Associated Covered Drug or Biological3 | Name of Associated Covered Drug or Biological4 | Name of Associated Covered Drug or Biological5 | NDC of Associated Covered Drug or Biological1 | NDC of Associated Covered Drug or Biological2 | NDC of Associated Covered Drug or Biological3 | NDC of Associated Covered Drug or Biological4 | NDC of Associated Covered Drug or Biological5 | Name of Associated Covered Device or Medical Supply1 | Name of Associated Covered Device or Medical Supply2 | Name of Associated Covered Device or Medical Supply3 | Name of Associated Covered Device or Medical Supply4 | Name of Associated Covered Device or Medical Supply5 | Total Amount of Payment USDollars | Date of Payment | Form of Payment or Transfer of Value | Expenditure Category1 | Expenditure Category2 | Expenditure Category3 | Expenditure Category4 | Expenditure Category5 | Expenditure Category6 | Is Preclinical Research Indicator | Is Delay in Publication Indicator | Name of Study | Is Dispute Status for Publication | Record ID | Program Year | Payment Publication Date | ClinicalTrials Gov Identifier | Research Information Link | Context of Research |
UNCHANGED | Covered Recipient Physician | 201803.0 | Christopher | Lucasti | 4290 Glendale Milford | Cincinnati | OH | 45242 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease | NJ | Merck Sharp & Dohme Corporation | 100000000053 | Merck Sharp & Dohme Corporation | NJ | United States | Covered | MK-7655 | 1217 | 2013-10-17 | In-kind items and services | False | False | A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with C | False | 281345170 | 2013 | 2020-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Physician | 346072.0 | KEVIN | D | MULLEN | 2500 METROHEALTH DR | CLEVELAND | OH | 44109 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology | OH | Merck Sharp & Dohme Corporation | 100000000053 | Merck Sharp & Dohme Corporation | NJ | United States | Covered | VICTRELIS | 85031402.0 | 106062926.0 | 209 | 2013-10-25 | In-kind items and services | False | False | A Phase 3 Safety and Efficacy Study of BoceprevirPeginterferon Alfa 2aribavirin in Chronic HCV Genotype 1 IL28B CC Subjects Protocol No P07755 also known as MK 3034 040 00 | False | 106062926 | 2013 | 2020-01-17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Teaching Hospital | 140119.0 | 433.0 | Rush University Medical Center | 1653 W. CONGRESS PARKWAY | CHICAGO | IL | 60612 | United States | 1108892.0 | ROHAM | MOFTAKHAR | 3 RICHLAND MEDICAL PARK DR | SUITE 310 | COLUMBIA | SC | 29203-6849 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Neurological Surgery | IL | SC | WA | WI | 63299.0 | ANDREW | KELLY | JOHNSON | 1653 W CONGRESS PKWY | CHICAGO | IL | 60612-3833 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Neurological Surgery | GA | IL | 53027.0 | DEMETRIUS | K | LOPES | 1725 W HARRISON ST | SUITE 855 | CHICAGO | IL | 60612-3841 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Neurological Surgery | IL | 100458.0 | MICHAEL | W | CHEN | 201 RIDGE ST | STE. 311 | COUNCIL BLUFFS | IA | 51503-4643 | United States | Doctor of Osteopathy | Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology | IA | NE | Siemens Medical Solutions USA, Inc. | 100000010755 | Siemens Medical Solutions USA, Inc. | PA | United States | Combination | AX - Angiography Fluoroscopy/Radiology | 37994 | 2013-10-28 | Cash or cash equivalent | False | False | Eval of improved IQ of c-arm images using new algorithms for MAR and cone beam artifact reduction Rush-2012-AX-01-40003-01-Lopes | False | 298827354 | 2013 | 2020-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Teaching Hospital | 450076.0 | 933.0 | University Of Texas M. D. Anderson Cancer Center | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | United States | 327012.0 | LUIS | FAYAD | MD ANDERSON CANCER CENTER | 1515 HOLCOMBE UNIT 429 | HOUSTON | TX | 77030 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology | TX | Pfizer Inc. | 100000000286 | Pfizer Inc. | NY | United States | Non-Covered | 456 | 2013-12-18 | Cash or cash equivalent | False | False | AN OPENLABEL RANDOMIZED PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN ADMINISTERED IN COMBINATION WITH RITUXIMAB COMPARED TO DEFINED INVESTIGATORS CHOICE THERAPY IN SUBJECTS WITH RELAPSED OR REFRACTORY CD22POSITIVE AGGRESSIVE NONHODGKIN LYMPHOMA WHO A | False | 207528508 | 2013 | 2020-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Physician | 50226.0 | MAMTA | K | JAIN | 1936 AMELIA CT | DALLAS | TX | 75235 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease | TX | ViiV Healthcare Company | 100000005550 | ViiV Healthcare Company | NC | United States | Non-Covered | TRELAVUE | 31 | 2013-09-20 | Cash or cash equivalent | False | False | A Phase IIIb randomized openlabel study of the safety and efficacy of dolutegravirabacavirlamivudine once daily compared to atazanavir and ritonavir plus tenofoviremtricitabine once daily in HIV1 infected antiretroviral therapy naive women | False | 106200718 | 2013 | 2020-01-17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Physician | 201803.0 | CHRISTOPHER | LUCASTI | 732 SHORE RD | SOMERS POINT | NJ | 8244 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease | NJ | Merck Sharp & Dohme Corporation | 100000000053 | Merck Sharp & Dohme Corporation | NJ | United States | Covered | MK-7655 | 1217 | 2013-12-28 | In-kind items and services | False | False | A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with C | False | 281345496 | 2013 | 2020-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Physician | 831829.0 | CHRISTIAN | GERALD | SCHROCK | 3366 OAKDALE AVE N STE 520 | MINNEAPOLIS | MN | 55422 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease | MN | Merck Sharp & Dohme Corporation | 100000000053 | Merck Sharp & Dohme Corporation | NJ | United States | Covered | MK-7655 | 110 | 2013-12-20 | In-kind items and services | False | False | A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 & ImipenemCilastatin Versus ImipenemCilastatin Alone in Patients with C | False | 281402710 | 2013 | 2020-01-17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Physician | 11323.0 | JASON | FOERST | 127 Mcclanahan St Sw | Ste 300 | Roanoke | VA | 24014 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine | NH | Medtronic Vascular, Inc. | 100000010384 | Medtronic Vascular, Inc. | MN | United States | Non-Covered | 1140 | 2013-10-24 | Cash or cash equivalent | False | False | CoreValve EUS | False | 105889913 | 2013 | 2020-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Teaching Hospital | 160058.0 | 582.0 | State University Of Iowa | 200 Hawkins Dr | Iowa City | IA | 52242 | United States | 1045914.0 | SIF | HANSDOTTIR | 200 HAWKINS DR | IOWA CITY | IA | 52242-1009 | United States | Medical Doctor | Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease | IA | Actelion Pharmaceuticals US, Inc. | 100000000253 | Actelion Clinical Research, Inc. | NJ | United States | Covered | OPSUMIT MACITENTAN | 6621550130.0 | 3575 | 2013-12-04 | In-kind items and services | False | False | SERAPHIN OL HQ - AC-055-303 | False | 30241682 | 2013 | 2020-01-17 | NCT00667823 | http://clinicaltrials.gov/ct2/show/NCT00667823?term=actelion+seraphin+ol&rank=1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNCHANGED | Covered Recipient Teaching Hospital | 380009.0 | 1050.0 | Oregon Health & Science University | 3181 SW Sam Jackson Park Rd | Mailcode CR96 | Portland | OR | 97239 | United States | Pfizer Inc. | 100000000286 | Pfizer Inc. | NY | United States | Covered | SUTENT | 69055038.0 | 3920 | 2013-12-17 | Cash or cash equivalent | True | False | False | 207658759 | 2013 | 2020-01-17 |